BioAge Labs Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug '26 Aug 3, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Market Cap	457	495	208	-	-
Market Cap Growth	188.11%	138.29%	-	-	-
Enterprise Value	84.14	219.09	-138.07	0	0
Last Close Price	10.27	13.23	5.79	-	-
PS Ratio	45.07	54.99	-	-	-
PB Ratio	1.06	1.82	0.64	-	-
P/TBV Ratio	1.02	1.75	0.19	-	-
EV/Sales Ratio	8.16	24.36	-	-	-
EV/EBITDA Ratio	-	-	1.77	-	-
EV/EBIT Ratio	-	-	1.77	-	-
EV/FCF Ratio	-	-	2.66	-	-
Debt / Equity Ratio	0.01	0.01	0.01	-0.71	0.11
Net Debt / Equity Ratio	-1.00	-1.01	-1.07	-0.06	0.22
Net Debt / EBITDA Ratio	3.74	2.98	4.43	-0.21	0.63
Net Debt / FCF Ratio	4.28	3.35	6.66	-0.27	0.69
Asset Turnover	0.03	0.03	0	0	0
Quick Ratio	24.26	14.00	12.76	0.43	4.72
Current Ratio	24.76	14.24	12.86	0.44	4.78
Return on Equity (ROE)	-27.62%	-27.09%	-50.35%	622.63%	-197.00%
Return on Assets (ROA)	-29.37%	-28.41%	-40.71%	-178.09%	-140.59%
Return on Invested Capital (ROIC)	-1074.86%	-994.48%	-449.15%	-344.47%	-6499.02%
Return on Capital Employed (ROCE)	-30.98%	-30.66%	-52.44%	1000.41%	-177.10%
Buyback Yield / Dilution	-95.07%	-234.99%	-541.23%	-0.06%	-
Total Shareholder Return	-95.07%	-234.99%	-541.23%	-0.06%	-

SEC Filings: 10-K · 10-Q